Статті в журналах з теми "ATP-competitive"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "ATP-competitive".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Lebakken, Connie S., Laurie J. Reichling, Jason M. Ellefson, and Steven M. Riddle. "Detection of Allosteric Kinase Inhibitors by Displacement of Active Site Probes." Journal of Biomolecular Screening 17, no. 6 (March 26, 2012): 813–21. http://dx.doi.org/10.1177/1087057112439889.
Повний текст джерелаAgius, Michael P., Kristin Ko, Taylor K. Johnson, Sameer Phadke, and Matthew B. Soellner. "Conformation-tunable ATP-competitive kinase inhibitors." Chemical Communications 58, no. 21 (2022): 3541–44. http://dx.doi.org/10.1039/d1cc06893h.
Повний текст джерелаGaruti, L., M. Roberti, and G. Bottegoni. "Non-ATP Competitive Protein Kinase Inhibitors." Current Medicinal Chemistry 17, no. 25 (September 1, 2010): 2804–21. http://dx.doi.org/10.2174/092986710791859333.
Повний текст джерелаLee, Byung-Il, Hyung-Jun Ahn, Ki-Cheol Han, Dae-Ro Ahn, and Dong-Yun Shin. "Pyrogallin, an ATP-Competitive Inhibitor of JAK3." Bulletin of the Korean Chemical Society 32, no. 3 (March 20, 2011): 1077–79. http://dx.doi.org/10.5012/bkcs.2011.32.3.1077.
Повний текст джерелаSchenone, S., C. Brullo, F. Musumeci, M. Radi, and M. Botta. "ATP-Competitive Inhibitors of mTOR: An Update." Current Medicinal Chemistry 18, no. 20 (July 1, 2011): 2995–3014. http://dx.doi.org/10.2174/092986711796391651.
Повний текст джерелаLazaro, Glorianne, Eleftherios Kostaras, and Igor Vivanco. "Inhibitors in AKTion: ATP-competitive vs allosteric." Biochemical Society Transactions 48, no. 3 (May 26, 2020): 933–43. http://dx.doi.org/10.1042/bst20190777.
Повний текст джерелаParrish, Cynthia A., Nicholas D. Adams, Kurt R. Auger, Joelle L. Burgess, Jeffrey D. Carson, Amita M. Chaudhari, Robert A. Copeland, et al. "Novel ATP-Competitive Kinesin Spindle Protein Inhibitors." Journal of Medicinal Chemistry 50, no. 20 (October 2007): 4939–52. http://dx.doi.org/10.1021/jm070435y.
Повний текст джерелаIto, Masahiro, Misa Iwatani, Yusuke Kamada, Satoshi Sogabe, Shoichi Nakao, Toshio Tanaka, Tomohiro Kawamoto, Samuel Aparicio, Atsushi Nakanishi, and Yasuhiro Imaeda. "Discovery of selective ATP-competitive eIF4A3 inhibitors." Bioorganic & Medicinal Chemistry 25, no. 7 (April 2017): 2200–2209. http://dx.doi.org/10.1016/j.bmc.2017.02.035.
Повний текст джерелаZarębska, Ewa A., Krzysztof Kusy, Ewa M. Słomińska, Łukasz Kruszyna, and Jacek Zieliński. "Plasma Nucleotide Dynamics during Exercise and Recovery in Highly Trained Athletes and Recreationally Active Individuals." BioMed Research International 2018 (October 9, 2018): 1–11. http://dx.doi.org/10.1155/2018/4081802.
Повний текст джерелаLyle, S., D. H. Geller, K. Ng, J. Stanczak, J. Westley, and N. B. Schwartz. "Kinetic mechanism of adenosine 5′-phosphosulphate kinase from rat chondrosarcoma." Biochemical Journal 301, no. 2 (July 15, 1994): 355–59. http://dx.doi.org/10.1042/bj3010355.
Повний текст джерелаTakahashi, Hideyuki, and Hideo Namiki. "Mechanism of membrane redistribution of protein kinase C by its ATP-competitive inhibitors." Biochemical Journal 405, no. 2 (June 27, 2007): 331–40. http://dx.doi.org/10.1042/bj20070299.
Повний текст джерелаQuartieri, Francesca, Marcella Nesi, Nilla R. Avanzi, Daniela Borghi, Elena Casale, Emiliana Corti, Ulisse Cucchi, et al. "Identification of unprecedented ATP-competitive choline kinase inhibitors." Bioorganic & Medicinal Chemistry Letters 51 (November 2021): 128310. http://dx.doi.org/10.1016/j.bmcl.2021.128310.
Повний текст джерелаTang, Colin P., Owen Clark, John R. Ferrarone, Carl Campos, Alshad S. Lalani, John D. Chodera, Andrew M. Intlekofer, Olivier Elemento, and Ingo K. Mellinghoff. "GCN2 kinase activation by ATP-competitive kinase inhibitors." Nature Chemical Biology 18, no. 2 (December 23, 2021): 207–15. http://dx.doi.org/10.1038/s41589-021-00947-8.
Повний текст джерелаFreeman-Cook, Kevin D., Christopher Autry, Gary Borzillo, Deborah Gordon, Elsa Barbacci-Tobin, Vincent Bernardo, David Briere, et al. "Design of Selective, ATP-Competitive Inhibitors of Akt." Journal of Medicinal Chemistry 53, no. 12 (June 24, 2010): 4615–22. http://dx.doi.org/10.1021/jm1003842.
Повний текст джерелаTunnicliff, G., and T. L. Youngs. "Competitive Inhibition of Mouse Brain -Aminobutyrate Aminotransferase by ATP." Experimental Biology and Medicine 192, no. 1 (October 1, 1989): 11–15. http://dx.doi.org/10.3181/00379727-192-42947.
Повний текст джерелаPapa, F. R. "Bypassing a Kinase Activity with an ATP-Competitive Drug." Science 302, no. 5650 (November 28, 2003): 1533–37. http://dx.doi.org/10.1126/science.1090031.
Повний текст джерелаHuck, Bayard R., and Igor Mochalkin. "Recent progress towards clinically relevant ATP-competitive Akt inhibitors." Bioorganic & Medicinal Chemistry Letters 27, no. 13 (July 2017): 2838–48. http://dx.doi.org/10.1016/j.bmcl.2017.04.090.
Повний текст джерелаQuintás-Cardama, A. "Experimental non-ATP-competitive therapies for chronic myelogenous leukemia." Leukemia 22, no. 5 (March 6, 2008): 932–40. http://dx.doi.org/10.1038/leu.2008.47.
Повний текст джерелаBarf, Tjeerd, Allard Kaptein, Sander de Wilde, Ruud van der Heijden, Richard van Someren, Dennis Demont, Carsten Schultz-Fademrecht, et al. "Structure-based lead identification of ATP-competitive MK2 inhibitors." Bioorganic & Medicinal Chemistry Letters 21, no. 12 (June 2011): 3818–22. http://dx.doi.org/10.1016/j.bmcl.2011.04.018.
Повний текст джерелаZhang, Dingwa, Deyong He, Xiaoliang Pan, and Lijun Liu. "Systematic profiling of ATP response to acquired drug-resistant EGFR family kinase mutations." Journal of the Serbian Chemical Society 85, no. 10 (2020): 1265–78. http://dx.doi.org/10.2298/jsc191124028z.
Повний текст джерелаPinzi, Luca. "On the development of B-Raf inhibitors acting through innovative mechanisms." F1000Research 11 (April 26, 2022): 237. http://dx.doi.org/10.12688/f1000research.108761.2.
Повний текст джерелаPinzi, Luca. "On the development of B-Raf inhibitors acting through innovative mechanisms." F1000Research 11 (April 26, 2022): 237. http://dx.doi.org/10.12688/f1000research.108761.2.
Повний текст джерелаPinzi, Luca. "On the development of B-Raf inhibitors acting through innovative mechanisms." F1000Research 11 (February 25, 2022): 237. http://dx.doi.org/10.12688/f1000research.108761.1.
Повний текст джерелаWilson, Brice A. P., Muhammad S. Alam, Tad Guszczynski, Michal Jakob, Shilpa R. Shenoy, Carter A. Mitchell, Ekaterina I. Goncharova, et al. "Discovery and Characterization of a Biologically Active Non–ATP-Competitive p38 MAP Kinase Inhibitor." Journal of Biomolecular Screening 21, no. 3 (November 4, 2015): 277–89. http://dx.doi.org/10.1177/1087057115615518.
Повний текст джерелаKhandekar, Sanjay S., Bingbing Feng, Tracey Yi, Susan Chen, Nicholas Laping, and Neal Bramson. "A Liquid Chromatography/Mass Spectrometry-Based Method for the Selection of ATP Competitive Kinase Inhibitors." Journal of Biomolecular Screening 10, no. 5 (August 2005): 447–55. http://dx.doi.org/10.1177/1087057105274846.
Повний текст джерелаChung, Vincent, Ling Wang, Margaret S. Fletcher, Erminia Massarelli, Karen L. Reckamp, Mihaela C. Cristea, Nikeeta Prajapati, et al. "First-time in-human study of VMD-928, an allosteric and irreversible TrkA selective inhibitor, in patients with solid tumors or lymphoma." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): TPS3146. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.tps3146.
Повний текст джерелаSchenone, S., C. Brullo, and M. Botta. "Small Molecules ATP-Competitive Inhibitors of FLT3: A Chemical Overview." Current Medicinal Chemistry 15, no. 29 (December 1, 2008): 3113–32. http://dx.doi.org/10.2174/092986708786848613.
Повний текст джерелаMa, Bin, Doug Marcotte, Murugan Paramasivam, Klaus Michelsen, Ti Wang, Andrea Bertolotti-Ciarlet, John Howard Jones, et al. "ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis." PLOS ONE 11, no. 11 (November 10, 2016): e0165983. http://dx.doi.org/10.1371/journal.pone.0165983.
Повний текст джерелаKarni, Rotem, Sarit Mizrachi, Ella Reiss-Sklan, Aviv Gazit, Oded Livnah, and Alexander Levitzki. "The pp60c-Src inhibitor PP1 is non-competitive against ATP." FEBS Letters 537, no. 1-3 (January 29, 2003): 47–52. http://dx.doi.org/10.1016/s0014-5793(03)00069-3.
Повний текст джерелаShen, Guobing, Miaoqing Liu, Jianjun Lu, and Tao Meng. "Practical synthesis of Vistusertib (AZD2014), an ATP competitive mTOR inhibitor." Tetrahedron Letters 60, no. 52 (December 2019): 151333. http://dx.doi.org/10.1016/j.tetlet.2019.151333.
Повний текст джерелаWu, Ke, Jingzhi Pang, Dong Song, Ying Zhu, Congwen Wu, Tianqu Shao, and Haifeng Chen. "Selectivity Mechanism of ATP-Competitive Inhibitors for PKB and PKA." Chemical Biology & Drug Design 86, no. 1 (November 28, 2014): 9–18. http://dx.doi.org/10.1111/cbdd.12472.
Повний текст джерелаFreeman-Cook, Kevin D., Christopher Autry, Gary Borzillo, Deborah Gordon, Elsa Barbacci-Tobin, Vincent Bernardo, David Briere, et al. "Corrections to Design of Selective, ATP-Competitive Inhibitors of Akt." Journal of Medicinal Chemistry 53, no. 15 (August 12, 2010): 5895. http://dx.doi.org/10.1021/jm100769x.
Повний текст джерелаGarc�a-Echeverr�a, Carlos, Peter Traxler, and Dean B. Evans. "ATP site-directed competitive and irreversible inhibitors of protein kinases." Medicinal Research Reviews 20, no. 1 (January 2000): 28–57. http://dx.doi.org/10.1002/(sici)1098-1128(200001)20:1<28::aid-med2>3.0.co;2-2.
Повний текст джерелаWang, Ruixiu, and James E. Thompson. "Detection of ATP Competitive Protein Kinase Inhibition by Western Blotting." Analytical Biochemistry 299, no. 1 (December 2001): 110–12. http://dx.doi.org/10.1006/abio.2001.5410.
Повний текст джерелаKirkland, Lindsay O., and Campbell McInnes. "Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics." Biochemical Pharmacology 77, no. 10 (May 2009): 1561–71. http://dx.doi.org/10.1016/j.bcp.2008.12.022.
Повний текст джерелаRosborough, Brian, Dàlia Raïch-Regué, Benjamin Matta, Keunwook Lee, Mark Boothby, Heth Turnquist та Angus Thomson. "Rapamycin-resistant mTORC1 restrains dendritic cell B7-H1 expression that requires IL-1β to enhance regulatory T cell induction (P1349)". Journal of Immunology 190, № 1_Supplement (1 травня 2013): 63.27. http://dx.doi.org/10.4049/jimmunol.190.supp.63.27.
Повний текст джерелаRoulin, Didier, Nicolas Demartines, and Olivier Dormond. "ATP-competitive inhibitors of mTOR: new perspectives in the treatment of renal cell carcinoma." Biochemical Society Transactions 39, no. 2 (March 22, 2011): 492–94. http://dx.doi.org/10.1042/bst0390492.
Повний текст джерелаLi, Chunqiong, Xuewen Zhang, Na Zhang, Yue Zhou, Guohui Sun, Lijiao Zhao, and Rugang Zhong. "Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening." Molecules 25, no. 1 (January 6, 2020): 237. http://dx.doi.org/10.3390/molecules25010237.
Повний текст джерелаO’Connor, Suzanne, Yann-Vaï Le Bihan, Isaac M. Westwood, Manjuan Liu, Oi Wei Mak, Gabriel Zazeri, Ana P. R. Povinelli, et al. "Discovery and Characterization of a Cryptic Secondary Binding Site in the Molecular Chaperone HSP70." Molecules 27, no. 3 (January 26, 2022): 817. http://dx.doi.org/10.3390/molecules27030817.
Повний текст джерелаXu, Jimin, Jing Ai, Sheng Liu, Xia Peng, Linqian Yu, Meiyu Geng, and Fajun Nan. "Design and synthesis of 3,3′-biscoumarin-based c-Met inhibitors." Org. Biomol. Chem. 12, no. 22 (2014): 3721–34. http://dx.doi.org/10.1039/c4ob00364k.
Повний текст джерелаNapoleon, John V., Sarbjit Singh, Sandeep Rana, Mourad Bendjennat, Vikas Kumar, Smitha Kizhake, Nicholas Y. Palermo, Michel M. Ouellette, Tom Huxford, and Amarnath Natarajan. "Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive manner." Chemical Communications 57, no. 38 (2021): 4678–81. http://dx.doi.org/10.1039/d1cc01245b.
Повний текст джерелаShapiro, Adam B., Helen Plant, Jarrod Walsh, Mark Sylvester, Jun Hu, Ning Gao, Stephania Livchak, Sharon Tentarelli, and Jason Thresher. "Discovery of ATP-Competitive Inhibitors of tRNAIle Lysidine Synthetase (TilS) by High-Throughput Screening." Journal of Biomolecular Screening 19, no. 8 (May 12, 2014): 1137–46. http://dx.doi.org/10.1177/1087057114534981.
Повний текст джерелаKatari, Naresh Kumar, Rambabu Gundla, Phani Kumar Reddy, Anuradha Vanam, Aruna Talatam, Noboru Motohashi, and Rao Gollapudi. "Molecular Docking Studies of Glabrene and Human Epidermal Growth Factor Receptor Kinase." INNOSC Theranostics and Pharmacological Sciences 4, no. 1 (April 29, 2022): 38–49. http://dx.doi.org/10.36922/itps.v4i1.56.
Повний текст джерелаCuthbertson, Peter, Amal Elhage, Dena Al-Rifai, Reece A. Sophocleous, Ross J. Turner, Ashraf Aboelela, Hiwa Majed, et al. "6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist." Biomolecules 12, no. 9 (September 16, 2022): 1309. http://dx.doi.org/10.3390/biom12091309.
Повний текст джерелаMcArdell, J. E. C., C. J. Bruton, and T. Atkinson. "The isolation of a peptide from the catalytic domain of Bacillus stearothermophilus tryptophyl-tRNA synthetase. The interaction of Brown MX-5BR with tyrosyl-tRNA synthetase." Biochemical Journal 243, no. 3 (May 1, 1987): 701–7. http://dx.doi.org/10.1042/bj2430701.
Повний текст джерелаPark, Seojeong, Soo-Yeon Hwang, Jaeho Shin, Hyunji Jo, Younghwa Na, and Youngjoo Kwon. "A chromenone analog as an ATP-competitive, DNA non-intercalative topoisomerase II catalytic inhibitor with preferences toward the alpha isoform." Chemical Communications 55, no. 85 (2019): 12857–60. http://dx.doi.org/10.1039/c9cc05524j.
Повний текст джерелаDeans, N. L., R. D. Allison, and D. L. Purich. "Steady-state kinetic mechanism of bovine brain tubulin: tyrosine ligase." Biochemical Journal 286, no. 1 (August 15, 1992): 243–51. http://dx.doi.org/10.1042/bj2860243.
Повний текст джерелаCozza, Giorgio, Andrea Bortolato, Ernesto Menta, Ennio Cavalletti, Silvano Spinelli, and Stefano Moro. "ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents." Anti-Cancer Agents in Medicinal Chemistry 9, no. 7 (September 1, 2009): 778–86. http://dx.doi.org/10.2174/187152009789056930.
Повний текст джерелаPitman, Melissa R., Jason A. Powell, Carl Coolen, Paul A. B. Moretti, Julia R. Zebol, Duyen H. Pham, John W. Finnie, et al. "A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties." Oncotarget 6, no. 9 (March 11, 2015): 7065–83. http://dx.doi.org/10.18632/oncotarget.3178.
Повний текст джерелаHornakova, T., L. Springuel, J. Devreux, A. Dusa, S. N. Constantinescu, L. Knoops, and J. C. Renauld. "Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors." Haematologica 96, no. 6 (March 10, 2011): 845–53. http://dx.doi.org/10.3324/haematol.2010.036350.
Повний текст джерела